Centre Hospitalier Victor Dupouy — Clinical Trial Site

75 Registered trials

25 Currently recruiting

Organisation

Centre Hospitalier Victor Dupouy

Location

Argenteuil Cedex, France

Identifier

ORG-100043255

Address

69 Rue Du Lieutenant Colonel Prudhon, 97107, France

Departments

#3307:Department of Intensive Care
#40742: Dermatologie
Anesthésie réanimation
Département d'hématologie
Département d’hématologie
DERMATOLOGIE
Dermatology department
Haematology
Hématologie
Hematology
Hematology Department
ICU
Immuno-Hématologie, Unité VIH-IST
Intensive care
Intensive care unit
Internal Medecine
Médecine Intensive - Réanimation
Médecine Intensive-Réanimation
Médecine Polyvalente-Médecine interne
Medical oncology
Medical Oncology Department
Multipurpose Resuscitation and continuous monitoring
Oncologie
Oncologie médicale
Oncology
Pneumologie
Pneumology
Réanimation
réanimation polyvalente
Réanimation Polyvalente & USC
Rhumatologie
Service d'hématologie
Service d'Urgence
Service d‘Hématologie
Service d’hématologie
Service de Dermatologie
Service de Pneumologie et d'Oncologie Thoracique
Service de Reanimation
Service de Réanimation Polyvalente
Service de soins intensifs
Service des Maladies Infectieuses et Tropicales
Service Hématologie

Clinical trials at this site (75)

Search interface

Prevention of secondary infections by interferon gamma in ICU-acquired sustained immune-suppression: a randomized trial Recruiting

2024-516780-93-00 Sustained immunosuppression 5 2025-07-09
MODULO Recruiting

2024-515793-27-01 HIV 5 2025-04-30
A Phase 3 efficacy and safety study of fosmanogepix for the treatment of adult participants with candidemia and/or invasive candidiasis. Recruiting

2022-500455-23-00 Candidemia 5 2024-12-11
This is a study to evaluate safety and efficacy of Upadacitinib comparing to Dupilumab in children from 2 to less than 12 years of age with … Recruiting

2023-504713-76-00 Dermatitis atopic 5 2024-12-03
A study to learn how bimekizumab works in children and teenagers with moderate to severe plaque psoriasis Recruiting

2023-503859-10-00 Moderate to Severe Plaque Psoriasis 5 2024-08-12
RIVACAST - RIVAroxaban versus low-molecular weight heparin in patients with lower limb trauma requiring brace or CASTing Recruiting

2023-509905-62-00 Lower limb trauma requiring immobilisation 5 2024-07-19
Phase 3 study to assess the efficacy and safety of Givinostat versus hydroxyurea in Polycythemia Vera patients Recruiting

2022-502276-23-00 JAK2V617F-positive high-risk Polycythemia Vera 5 2024-04-25
A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 Follicular lymphoma 5 2024-02-01
A trial to learn if odronextamab combined with lenalidomide is safe and works better than rituximab combined with lenalidomide in adult part… Recruiting

2022-503092-28-00 Relapsed/Refractory Follicular Lymphoma 5 2024-01-08
Early Oseltamivir Carboxylate Low Plasma Concentration in Patients Admitted to Intensive Care for Severe Influenza. Recruiting

2024-516058-23-00 Adult patients admitted to the ICU for management of se 5 2023-12-18
Benefit of transplantation after Complete Response In Patients with T-cell lymphoma Recruiting

2022-501710-62-02 Peripheral T-cell lymphoma (PTCL) 6 2023-06-07
Piperacillin-tazobactam and temocillin as carbapenem-alternatives for the treatment of severe infections due to extended-spectrum beta-lacta… Recruiting

2024-511866-36-00 patients hospitalized in ICU with ESBL-producing Entero 5 2023-03-11
ASPIC - Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care Recruiting

2024-513327-16-00 Intensive care 5 2022-09-20
A randomized phase I/ II multicenter study evaluating combination of luspatercept in LR-MDS without RS having failed or being ineligible to … Recruiting

2024-515354-24-00 Low risk myelodysplastic syndrom without RS having fail 9 2022-05-18
Short Treatment With Omalizumab for Severe Asthma (SHORTEN) Recruiting

2024-513427-17-00 Well controlled severe allergic asthma 6 2021-05-20
A multicenter, prospective, randomized, placebo-controlled, double-blind, multi-arm, multi-stage clinical trial of Ivabradine for heart Rate… Recruiting

2024-515019-22-00 Septic shock 5 2021-02-26
CLAZI : CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections: A randomized prospective co… Recruiting

2024-518578-15-00 Is to demonstrate a non inferior efficacy of azithromyc 5 2018-02-05
GRAALL2014 Recruiting

2024-516103-16-00 Acute Lymphoblastic Leukemia (ALL) in younger adults (1 4 2015-12-04
Phase 3 trial aimed at improving the overall survival of AML in adults aged 18 to 60 by comparing high-dose idarubicin with daunorubicin at … Ended

2024-516873-57-00 Acute myeloid leukemia in adults aged 18 to 60 10 2026-01-13
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination with Intravenously… Ended

2024-512147-23-00 Chronic Lymphocytic Leukemia 10 2024-11-21
STUDY AGORA-1 / ALFA 2100: Phase 2 on the combinaison of Gemtuzumab Ozogamicin witk gilteritinib in adult patients with acute myeloid leukem… Ended

2023-504176-25-00 Acute Myeloid Leukemia 9 2024-08-08
PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed… Ended

2023-505972-32-00 locally advanced anal squamous cell carcinoma 5 2024-02-26
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatm… Ended

2023-505120-59-00 Moderate to Severe Plaque Psoriasis 5 2023-12-19
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Ended

2022-501024-20-00 ER+/HER2- Early Breast Cancer 5 2023-07-25